Does the media refer more to INNV or LFST?

In the previous week, LifeStance Health Group had 15 more articles in the media than InnovAge. MarketBeat recorded 19 mentions for LifeStance Health Group and 4 mentions for InnovAge. InnovAge's average media sentiment score of 1.78 beat LifeStance Health Group's score of 0.50 indicating that InnovAge is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive LifeStance Health Group 5 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, BLLN or INNV?

Billiontoone has higher earnings, but lower revenue than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Billiontoone $305.11M 14.43 $7.45M $0.70 133.33 InnovAge $949.17M 1.52 -$30.31M -$0.09 N/A

Does the media prefer BLLN or INNV?

In the previous week, Billiontoone had 10 more articles in the media than InnovAge. MarketBeat recorded 14 mentions for Billiontoone and 4 mentions for InnovAge. InnovAge's average media sentiment score of 1.78 beat Billiontoone's score of 0.53 indicating that InnovAge is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 6 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive InnovAge 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has stronger earnings and valuation, INNV or OPCH?

Option Care Health has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InnovAge $949.17M 1.52 -$30.31M -$0.09 N/A Option Care Health $5.69B 0.63 $207.59M $1.33 18.00

Does the media favor INNV or OPCH?

In the previous week, InnovAge had 1 more articles in the media than Option Care Health. MarketBeat recorded 4 mentions for InnovAge and 3 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.91 beat InnovAge's score of 1.78 indicating that Option Care Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Option Care Health 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts rate CRVL or INNV?

InnovAge has a consensus target price of $7.00, indicating a potential downside of 34.02%. Given InnovAge's higher possible upside, analysts plainly believe InnovAge is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 InnovAge 2 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.33

Which has preferable valuation and earnings, CRVL or INNV?

CorVel has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CorVel $958.53M 3.50 $110.34M $2.25 29.21 InnovAge $949.17M 1.52 -$30.31M -$0.09 N/A

Is CRVL or INNV more profitable?

CorVel has a net margin of 11.72% compared to InnovAge's net margin of -1.22%. CorVel's return on equity of 29.92% beat InnovAge's return on equity. Company Net Margins Return on Equity Return on Assets CorVel 11.72% 29.92% 17.82% InnovAge -1.22% -4.73% -2.20%

Does the media refer more to CRVL or INNV?

In the previous week, CorVel and CorVel both had 4 articles in the media. InnovAge's average media sentiment score of 1.78 beat CorVel's score of 1.37 indicating that InnovAge is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InnovAge 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to PRVA or INNV?

In the previous week, Privia Health Group had 3 more articles in the media than InnovAge. MarketBeat recorded 7 mentions for Privia Health Group and 4 mentions for InnovAge. InnovAge's average media sentiment score of 1.78 beat Privia Health Group's score of 0.49 indicating that InnovAge is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InnovAge 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

InnovAge (INNV) Competitors

$10.61 -0.04 (-0.38%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$10.60 0.00 (-0.05%)

As of 08/14/2026 07:34 PM Eastern

Compare

INNV vs. LFST, BLLN, OPCH, CRVL, and PRVA

Should you buy InnovAge stock or one of its competitors? InnovAge's main competitors and comparable companies include LifeStance Health Group (LFST), Billiontoone (BLLN), Option Care Health (OPCH), CorVel (CRVL), and Privia Health Group (PRVA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does InnovAge compare to LifeStance Health Group?

InnovAge (NASDAQ:INNV) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings, analyst recommendations and media sentiment.

12.3% of InnovAge shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 1.0% of InnovAge shares are owned by insiders. Comparatively, 3.5% of LifeStance Health Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

InnovAge currently has a consensus target price of $7.00, indicating a potential downside of 34.02%. LifeStance Health Group has a consensus target price of $12.13, indicating a potential downside of 2.38%. Given LifeStance Health Group's stronger consensus rating and higher probable upside, analysts clearly believe LifeStance Health Group is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

LifeStance Health Group has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$949.17M	1.52	-$30.31M	-$0.09	N/A
LifeStance Health Group	$1.42B	3.38	$9.66M	$0.13	95.54

In the previous week, LifeStance Health Group had 15 more articles in the media than InnovAge. MarketBeat recorded 19 mentions for LifeStance Health Group and 4 mentions for InnovAge. InnovAge's average media sentiment score of 1.78 beat LifeStance Health Group's score of 0.50 indicating that InnovAge is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InnovAge	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
LifeStance Health Group	5 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

LifeStance Health Group has a net margin of 3.19% compared to InnovAge's net margin of -1.22%. LifeStance Health Group's return on equity of 3.39% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-1.22%	-4.73%	-2.20%
LifeStance Health Group	3.19%	3.39%	2.33%

InnovAge has a beta of 0.39, meaning that its stock price is 61% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.14, meaning that its stock price is 14% more volatile than the broader market.

Summary

LifeStance Health Group beats InnovAge on 16 of the 17 factors compared between the two stocks.

How does InnovAge compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and InnovAge (NASDAQ:INNV) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

12.3% of InnovAge shares are held by institutional investors. 50.2% of Billiontoone shares are held by company insiders. Comparatively, 1.0% of InnovAge shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Billiontoone has higher earnings, but lower revenue than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	14.43	$7.45M	$0.70	133.33
InnovAge	$949.17M	1.52	-$30.31M	-$0.09	N/A

Billiontoone presently has a consensus target price of $126.71, suggesting a potential upside of 35.77%. InnovAge has a consensus target price of $7.00, suggesting a potential downside of 34.02%. Given Billiontoone's stronger consensus rating and higher probable upside, analysts plainly believe Billiontoone is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
InnovAge	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33

Billiontoone has a net margin of 8.04% compared to InnovAge's net margin of -1.22%. Billiontoone's return on equity of 9.96% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	8.04%	9.96%	5.35%
InnovAge	-1.22%	-4.73%	-2.20%

In the previous week, Billiontoone had 10 more articles in the media than InnovAge. MarketBeat recorded 14 mentions for Billiontoone and 4 mentions for InnovAge. InnovAge's average media sentiment score of 1.78 beat Billiontoone's score of 0.53 indicating that InnovAge is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	6 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
InnovAge	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Billiontoone beats InnovAge on 12 of the 15 factors compared between the two stocks.

How does InnovAge compare to Option Care Health?

InnovAge (NASDAQ:INNV) and Option Care Health (NASDAQ:OPCH) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations, valuation and media sentiment.

InnovAge presently has a consensus target price of $7.00, indicating a potential downside of 34.02%. Option Care Health has a consensus target price of $29.92, indicating a potential upside of 24.99%. Given Option Care Health's stronger consensus rating and higher probable upside, analysts plainly believe Option Care Health is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33
Option Care Health	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50

Option Care Health has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$949.17M	1.52	-$30.31M	-$0.09	N/A
Option Care Health	$5.69B	0.63	$207.59M	$1.33	18.00

In the previous week, InnovAge had 1 more articles in the media than Option Care Health. MarketBeat recorded 4 mentions for InnovAge and 3 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.91 beat InnovAge's score of 1.78 indicating that Option Care Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InnovAge	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Option Care Health	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

InnovAge has a beta of 0.39, indicating that its stock price is 61% less volatile than the broader market. Comparatively, Option Care Health has a beta of 0.65, indicating that its stock price is 35% less volatile than the broader market.

12.3% of InnovAge shares are owned by institutional investors. Comparatively, 98.1% of Option Care Health shares are owned by institutional investors. 1.0% of InnovAge shares are owned by company insiders. Comparatively, 1.7% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Option Care Health has a net margin of 3.68% compared to InnovAge's net margin of -1.22%. Option Care Health's return on equity of 18.74% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-1.22%	-4.73%	-2.20%
Option Care Health	3.68%	18.74%	7.25%

Summary

Option Care Health beats InnovAge on 14 of the 16 factors compared between the two stocks.

How does InnovAge compare to CorVel?

CorVel (NASDAQ:CRVL) and InnovAge (NASDAQ:INNV) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

In the previous week, CorVel and CorVel both had 4 articles in the media. InnovAge's average media sentiment score of 1.78 beat CorVel's score of 1.37 indicating that InnovAge is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InnovAge	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

51.4% of CorVel shares are held by institutional investors. Comparatively, 12.3% of InnovAge shares are held by institutional investors. 39.7% of CorVel shares are held by insiders. Comparatively, 1.0% of InnovAge shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

CorVel has a beta of 0.98, meaning that its stock price is 2% less volatile than the broader market. Comparatively, InnovAge has a beta of 0.39, meaning that its stock price is 61% less volatile than the broader market.

CorVel has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	3.50	$110.34M	$2.25	29.21
InnovAge	$949.17M	1.52	-$30.31M	-$0.09	N/A

InnovAge has a consensus target price of $7.00, indicating a potential downside of 34.02%. Given InnovAge's higher possible upside, analysts plainly believe InnovAge is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
InnovAge	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33

CorVel has a net margin of 11.72% compared to InnovAge's net margin of -1.22%. CorVel's return on equity of 29.92% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.72%	29.92%	17.82%
InnovAge	-1.22%	-4.73%	-2.20%

Summary

CorVel beats InnovAge on 12 of the 14 factors compared between the two stocks.

How does InnovAge compare to Privia Health Group?

Privia Health Group (NASDAQ:PRVA) and InnovAge (NASDAQ:INNV) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership.

Privia Health Group currently has a consensus target price of $31.00, suggesting a potential upside of 40.91%. InnovAge has a consensus target price of $7.00, suggesting a potential downside of 34.02%. Given Privia Health Group's stronger consensus rating and higher probable upside, analysts clearly believe Privia Health Group is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
InnovAge	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33

Privia Health Group has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.36B	1.19	$22.92M	$0.21	104.76
InnovAge	$949.17M	1.52	-$30.31M	-$0.09	N/A

Privia Health Group has a net margin of 1.19% compared to InnovAge's net margin of -1.22%. Privia Health Group's return on equity of 3.52% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	1.19%	3.52%	2.00%
InnovAge	-1.22%	-4.73%	-2.20%

Privia Health Group has a beta of 0.85, indicating that its share price is 15% less volatile than the broader market. Comparatively, InnovAge has a beta of 0.39, indicating that its share price is 61% less volatile than the broader market.

94.5% of Privia Health Group shares are held by institutional investors. Comparatively, 12.3% of InnovAge shares are held by institutional investors. 5.7% of Privia Health Group shares are held by company insiders. Comparatively, 1.0% of InnovAge shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Privia Health Group had 3 more articles in the media than InnovAge. MarketBeat recorded 7 mentions for Privia Health Group and 4 mentions for InnovAge. InnovAge's average media sentiment score of 1.78 beat Privia Health Group's score of 0.49 indicating that InnovAge is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InnovAge	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Privia Health Group beats InnovAge on 14 of the 16 factors compared between the two stocks.

Get InnovAge News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INNV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INNV vs. The Competition

Export

Metric	InnovAge	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.45B	$9.81B	$7.02B	$13.06B
Dividend Yield	N/A	2.55%	2.57%	10.45%
P/E Ratio	-117.89	35.17	271.27	25.33
Price / Sales	1.52	4.70	583.72	76.93
Price / Cash	N/A	124.34	70.48	50.90
Price / Book	6.03	3.94	12.92	6.25
Net Income	-$30.31M	$309.96M	$3.45B	$347.82M
7 Day Performance	-5.10%	0.09%	1.15%	1.08%
1 Month Performance	-8.38%	-0.33%	1.37%	0.82%
1 Year Performance	209.33%	19.52%	62.53%	20.99%

InnovAge Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INNV InnovAge	2.0965 of 5 stars	$10.61 -0.4%	$7.00 -34.0%	+200.6%	$1.45B	$949.17M	N/A	2,440	Positive News
LFST LifeStance Health Group	2.8254 of 5 stars	$11.50 -3.4%	$11.63 +1.1%	+122.6%	$4.62B	$1.42B	91.54	10,961	Analyst Upgrade Insider Trade
BLLN Billiontoone	4.4988 of 5 stars	$97.94 -0.7%	$126.71 +29.4%	N/A	$4.54B	$305.11M	140.93	620	News Coverage Insider Trade
OPCH Option Care Health	4.4077 of 5 stars	$24.08 -1.7%	$29.92 +24.3%	-15.7%	$3.67B	$5.65B	15.51	8,266	Positive News Analyst Upgrade
CRVL CorVel	1.4521 of 5 stars	$61.20 -0.8%	N/A	-25.7%	$3.15B	$958.53M	27.20	5,239	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INNV) was last updated on 8/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InnovAge (INNV) Competitors

INNV vs. LFST, BLLN, OPCH, CRVL, and PRVA

How does InnovAge compare to LifeStance Health Group?

Summary

How does InnovAge compare to Billiontoone?

Summary

How does InnovAge compare to Option Care Health?

Summary

How does InnovAge compare to CorVel?

Summary

How does InnovAge compare to Privia Health Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INNV vs. The Competition

InnovAge Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

InnovAge (INNV) Competitors

INNV vs. LFST, BLLN, OPCH, CRVL, and PRVA

How does InnovAge compare to LifeStance Health Group?

Do insiders and institutionals believe in INNV or LFST?

Do analysts recommend INNV or LFST?

Which has stronger earnings and valuation, INNV or LFST?

Does the media refer more to INNV or LFST?

Is INNV or LFST more profitable?

Which has more risk & volatility, INNV or LFST?

Summary

How does InnovAge compare to Billiontoone?

Do insiders and institutionals hold more shares of BLLN or INNV?

Which has stronger earnings and valuation, BLLN or INNV?

Do analysts recommend BLLN or INNV?

Is BLLN or INNV more profitable?

Does the media prefer BLLN or INNV?

Summary

How does InnovAge compare to Option Care Health?

Do analysts recommend INNV or OPCH?

Which has stronger earnings and valuation, INNV or OPCH?

Does the media favor INNV or OPCH?

Which has more risk & volatility, INNV or OPCH?

Do insiders and institutionals believe in INNV or OPCH?

Is INNV or OPCH more profitable?

Summary

How does InnovAge compare to CorVel?

Does the media refer more to CRVL or INNV?

Do institutionals and insiders have more ownership in CRVL or INNV?

Which has more volatility & risk, CRVL or INNV?

Which has preferable valuation and earnings, CRVL or INNV?

Do analysts rate CRVL or INNV?

Is CRVL or INNV more profitable?

Summary

How does InnovAge compare to Privia Health Group?

Do analysts rate PRVA or INNV?

Which has preferable earnings & valuation, PRVA or INNV?

Is PRVA or INNV more profitable?

Which has more volatility & risk, PRVA or INNV?

Do insiders & institutionals have more ownership in PRVA or INNV?

Does the media refer more to PRVA or INNV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INNV vs. The Competition

InnovAge Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools